300601-基本财务实时评分详情
康泰生物300601基本财务实时评分详情
更新时间:2020-11-28 00:00:01
股票代码
300601
当期评分
股票名称
康泰生物
报告日期2017-12-312018-12-312019-12-312020-03-312020-06-302020-06-30
每股经营现金流(¥)0.36560.52690.7838-0.11710.0387
销售净利润率(%)18.490221.601729.56291.36829.8652
销售毛利率(%)87.655190.564391.046991.195692.142
净资产收益率(%)20.0523.7720.860.094.02
营业增长率(%)110.380473.6949-3.6477-48.12257.7121
净利润增长率(%)149.0369102.924131.8626-97.56910.6337
每股收益(%)0.530.70.910.00380.4022
现金流量比率(%)19.831134.54558.1146-9.60183.1597
三项费用比重(%)68.841658.451449.438368.349747.9055
每股净资产(¥)2.54312.87024.26874.3219.6204
流动比率(%)1.27461.78662.10092.20225.7227
速动比率(%)1.04171.58531.83811.83475.3594
现金比率(%)20.573365.153358.059229.131629.1316
总资产利润率(%)11.265815.708415.76390.06184.5623
主营利润比重%427.6874373.4689266.6895116.5135268.2928
应收账款(万元)53,237.2985,546.61105,002.19102,797.58133,768.09
应收票据(万元)100.00229.8870.00116.5618.80
预付款项(万元)458.88979.091,231.391,781.494,468.75
存货(万元)18,083.4219,608.6722,875.9628,911.1729,885.05
在建工程(万元)38,600.6761,560.8446,228.5847,062.7942,476.37
应付款项(万元)5,364.739,170.5611,657.0511,164.149,663.49
长期借款(万元)22,743.2725,501.8319,501.8318,001.83--
未分配利润(万元)34,969.3861,671.6899,017.5199,259.93124,998.58
商誉(万元)----------
流动资产(万元)122,103.17159,621.37212,421.28215,737.38272,945.08
流动负债(万元)77,648.0797,402.4187,017.9378,660.3082,261.88
康泰生物300601评分结果
69.70分
买入/增持

copyright@ YOUVERY TECHNOLOGY CO., 厦门优极网络科技有限公司©
闽ICP备17005296号-3
地址:厦门市湖里区高崎道890号 邮编:361006